Foto del docente

Andrea Ardizzoni

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: MED/06 Medical Oncology

Head of Scuola di Specializzazione Oncologia Medica (DI 68/2015)

Publications

Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Francesca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes, «CANCERS», 2022, 14, Article number: 3472 , pp. 1 - 15 [Scientific article]Open Access

Donatella Romaniello, Valerio Gelfo, Federica Pagano, Enea Ferlizza, Michela Sgarzi, Martina Mazzeschi, Alessandra Morselli, Carmen Miano, Moshit Lindzen, Gabriele D’Uva, Francesco Fazi, Luca Tamagnone, Karim Rihawi, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola, IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization, in: ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, 2022, 126, pp. 117 - 117 (atti di: 75° Congresso Nazionale SIAI, Padova, 14-16 Settembre 2022) [Contribution to conference proceedings]

De Giglio, Andrea; Aprile, Marta; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Gelsomino, Francesco; Ardizzoni, Andrea, Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC), «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 10292 - 10299 [Scientific article]Open Access

Ambrosi F.; Giunchi F.; Capizzi E.; Cancellieri A.; Trisolini R.; Ardizzoni A.; Fiorentino M.; Ricci C., Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples, «PATHOLOGY RESEARCH AND PRACTICE», 2022, 233, Article number: 153893 , pp. 153893 - 153893 [Scientific article]

Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D.; Lamberti G., Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 1461 , pp. 1461 - 1478 [Scientific article]Open Access

Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea, Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2022, 14, pp. * - * [Scientific article]Open Access

de Biase, Dario; Maloberti, Thais; De Leo, Antonio; Sanza, Viviana; Visani, Michela; Gruppioni, Elisa; Altimari, Annalisa; Grillini, Alessia; Gelsomino, Francesco; Ferrari, Marco; Ardizzoni, Andrea; Tallini, Giovanni, Next-generation technologies in predictive molecular pathology of lung cancers, «Journal of Xiangya Medicine», 2022, 7, pp. 1 - 13 [Scientific article]Open Access

Hayashi, Hidetoshi; Nadal, Ernest; Gray, Jhanelle E; Ardizzoni, Andrea; Caria, Nicola; Puri, Tarun; Grohe, Christian, Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations, «CLINICAL LUNG CANCER», 2022, 23, pp. 69 - 82 [Scientific article]Open Access

De Giglio, Andrea; Grandinetti, Valeria; Aprile, Marta; Borelli, Greta; Campus, Anita; Croci Chiocchini, Anna Laura; Busutti, Marco; Vischini, Gisella; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea; La Manna, Gaetano; Gelsomino, Francesco, Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience, «LUNG CANCER», 2022, 174, pp. 91 - 96 [Scientific article]

Santoro, Armando; Su, Wu-Chou; Navarro, Alejandro; Simonelli, Matteo; Ch Yang, James; Ardizzoni, Andrea; Barlesi, Fabrice; Hyoung Kang, Jin; DiDominick, Sarah; Abdelhady, Ahmed; Chen, Xueying; Stammberger, Uz; Felip, Enriqueta, Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer, «LUNG CANCER», 2022, 166, pp. 170 - 177 [Scientific article]Open Access

Ricci A.D.; Rizzo A.; Mollica V.; Schiavina R.; Fiorentino M.; Brunocilla E.; Ardizzoni A.; Massari F., Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data, «ANTI-CANCER DRUGS», 2022, 33, pp. e61 - e68 [Scientific article]

Sisi, Monia; Fusaroli, Michele; De Giglio, Andrea; Facchinetti, Francesco; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2022, 17, pp. 43 - 51 [Scientific article]Open Access

Pantaleo M.A.; Urbini M.; Schipani A.; Nannini M.; Indio V.; De Leo A.; Vincenzi B.; Brunello A.; Grignani G.; Casagrande M.; Fumagalli E.; Conca E.; Saponara M.; Gruppioni E.; Altimari A.; De Biase D.; Tallini G.; Ravegnini G.; Turchetti D.; Seri M.; Ardizzoni A.; Secchiero P.; Astolfi A., SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor, «FRONTIERS IN ONCOLOGY», 2022, 11, Article number: 778461 , pp. 1 - 7 [Scientific article]Open Access

Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F., Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System, «AMERICAN JOURNAL OF CLINICAL DERMATOLOGY», 2022, 23, pp. 247 - 255 [Scientific article]

Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambrosi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Győrffy, Balázs; Palmer, Ruth; Lauriola, Mattia, The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2022, 41, pp. 113 - 131 [Scientific article]Open Access